Basking Ridge, NJ17 Active Studies

Spinal Muscular Atrophy Clinical Trials in Basking Ridge, NJ

Find 17 actively recruiting spinal muscular atrophy clinical trials in Basking Ridge, NJ. Connect with local research sites and explore new treatment options.

17
Active Trials
4
Sponsors
1,712
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Basking Ridge

About Spinal Muscular Atrophy Clinical Trials in Basking Ridge

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 17 spinal muscular atrophy clinical trials recruiting participants in Basking Ridge, NJ. These studies are seeking a combined 1,712 participants. Research is being sponsored by AstraZeneca, Taiho Oncology, Inc., Memorial Sloan Kettering Cancer Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Basking Ridge — FAQ

Are there spinal muscular atrophy clinical trials in Basking Ridge?

Yes, there are 17 spinal muscular atrophy clinical trials currently recruiting in Basking Ridge, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Basking Ridge?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Basking Ridge research site will contact you about next steps.

Are clinical trials in Basking Ridge free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Basking Ridge studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 17 active trials in Basking Ridge are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated October 16, 2026 from ClinicalTrials.gov